Judge Stands By $21M Jury Verdict In Sulindac Case

Law360, New York (January 7, 2011, 5:41 PM EST) -- A federal judge has shot down Mutual Pharmaceutical Co.'s attempt to overturn a jury award of $21 million to a woman who was blinded and suffered a near-fatal skin disease after taking the generic-drug company's anti-inflammatory drug Sulindac.

Judge Joseph Laplante of the U.S. District Court for the District of New Hampshire on Wednesday dismissed Mutual's motion for a new trial and motion for judgment as a matter of law, ruling that the damages were substantial but acceptable in light of the severe injuries plaintiff Karen...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.